Drug Discovery Innovations - Cell Based Assays, Phenotypic Screening and Pioneering Technologies will provide you with the latest leading-edge strategies being pursued to improve target identification and validation in early stage drug discovery and to improve R&D efficiency. The programme will address issues, breakthroughs and developments to improve your day to day role, identifying better quality candidate drugs to increase translation to clinical results.
Direct Mail Base Cost
85,431 US Contacts $225/M
43,697 International Contacts $225/M
Email
23,389 US Contacts $425/M*
14,584 International $425/M*
* Price includes transmission fee
Program Highlights:
Sourcing and Designing More Physiologically Relevant Cellular Assays for Implementation in HTS Programmes
Overcoming Patient Variability
Application of Genome Editing
Practical Strategies for Developing 3D Cell Culture Assays for Use in Drug Discovery
Phenotypic Screening and Complex Disease Assays
Target Deconvolution Strategies in Phenotypic Screening
Combination Screening
Image Analysis and Data Collection, Storage and Interpretation
Open-Access Collaboration in Accelerating Early Stage Drug Discovery
These lists have been tested and used by the conference teams to promote their own products and services for over 20 years.
Key Interest areas
Biology
Cancer research
Cell biology
Genetics
Molecular biology
Genomics
Immunology
Microbiology
Peptides
Proteomics/protein
Toxicology
Biotechnologies
Biomedical technology
Bioprocess
Biopharmaceutical
Medical device
Compliance/regulatory
Legal/Licensing/Intellectual property
Pharmaceutical manufacturing
Clinical trials
Clinical research
Drug discovery
And more, enquire if you don’t see what you need.
Contact Us for Counts
Join over 1,400 subscribers who receive the B2B Marketing Innovator
